These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2931000)

  • 1. A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicity.
    Hiserodt JC
    Adv Exp Med Biol; 1985; 184():139-60. PubMed ID: 2931000
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis.
    Kahle R; Hiserodt J; Bonavida B
    Cell Immunol; 1983 Aug; 80(1):97-104. PubMed ID: 6409429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
    Shinohara N; Kojima M
    J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system.
    Palladino MA; Ranges GE; Oettgen HF; Old LJ
    Adv Exp Med Biol; 1985; 184():355-64. PubMed ID: 3875974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of NK alloantigens on cloned cytotoxic T lymphocytes.
    Brooks CG; Burton RC; Pollack SB; Henney CS
    J Immunol; 1983 Sep; 131(3):1391-5. PubMed ID: 6604098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes.
    Main EK; Lampson LA; Hart MK; Kornbluth J; Wilson DB
    J Immunol; 1985 Jul; 135(1):242-6. PubMed ID: 3158702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
    Duke RC; Cohen JJ; Chervenak R
    J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of cytotoxic T cells in the rat mixed lymphocyte reaction is blocked by monoclonal antibody MRC OX-8.
    Green JR
    Immunology; 1984 Jun; 52(2):253-60. PubMed ID: 6234228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 12. Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.
    Shinohara N; Sachs DH
    J Exp Med; 1979 Sep; 150(3):432-44. PubMed ID: 113478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine Peyer's patches are capable of generating a cytotoxic T cell (CTL) response to nominal antigens.
    London SD; Rubin DH; Cebra JJ
    Adv Exp Med Biol; 1987; 216A():267-78. PubMed ID: 2891243
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of membrane markers on rat cytotoxic cells.
    Cantrell DA; Robins RA; Baldwin RW
    Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte function-associated antigens: regulation of lymphocyte adhesions in vitro and immunity in vivo.
    Martz E; Gromkowski SH
    Adv Exp Med Biol; 1985; 184():291-310. PubMed ID: 3898752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of natural killer cells in the allograft response.
    Hoffman RA; Jordan ML; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):342-4. PubMed ID: 3274782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.